Aplastic anemia is not a cancer. It is a form of bone marrow failure in which the marrow simply stops making enough blood cells, rather than filling up with malignant cells. The confusion is understandable, though: it is diagnosed with the same tests as leukemia, treated by hematologist-oncologists, sometimes managed with chemotherapy-like drugs, and in a minority of patients it can later evolve into a true blood cancer.
This guide explains why aplastic anemia is often discussed alongside cancer, what causes it, how doctors tell the two apart, and what treatment looks like today.
Why Aplastic Anemia Gets Mistaken for Cancer
Aplastic anemia sits at the crossroads of several hematologic conditions. Patients arrive with the same complaints as someone with acute leukemia: exhaustion, bruising, and infections that will not clear. Their blood count shows pancytopenia, a shortage of all types of blood cells at once.
The crucial difference is inside the marrow. In leukemia the marrow is packed with abnormal, rapidly dividing cells that crowd out normal production. In aplastic anemia the marrow is empty, largely replaced by fat, because the hematopoietic stem cells that should be making blood have been destroyed or have failed.
Several features keep the two conditions closely linked in practice:
- Both are cared for by the same specialists, often in the same cancer or transplant units.
- Some treatments overlap, including stem cell transplantation and powerful immune-suppressing drugs.
- Aplastic anemia can undergo clonal evolution, meaning a small abnormal cell population can emerge years later and develop into myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML).
- It overlaps with paroxysmal nocturnal hemoglobinuria (PNH), another acquired clonal marrow disorder.
| Feature | Aplastic anemia | Acute leukemia |
|---|---|---|
| Marrow cellularity | Low (hypocellular, fatty) | High (packed with blasts) |
| Main mechanism | Stem cell loss, usually immune attack | Malignant cell proliferation |
| Blast cells in blood | Absent | Often present |
| Spleen and lymph nodes | Usually normal size | May be enlarged |
| Standard treatment | Immunosuppression or transplant | Chemotherapy, targeted therapy, transplant |
Causes and Risk Factors
Most cases are acquired, developing during life rather than being present from birth. In the majority, no single trigger is found, and the disease is labelled idiopathic. The best-supported explanation is that the immune system mistakenly attacks the marrow’s own stem cells.
A smaller group of patients has an inherited marrow failure syndrome. The best known is Fanconi anemia, a DNA-repair disorder that also carries a genuine increased risk of leukemia and solid tumors. Defects in telomere maintenance genes such as TERC and TERT can also cause marrow failure, sometimes appearing first in adulthood.
Recognized acquired triggers include:
- Chemicals: benzene exposure is the classic example.
- Medications: chloramphenicol is historically the best known; some anti-seizure drugs, gold salts, and other agents have been implicated.
- Radiation and chemotherapy: these predictably suppress the marrow, usually temporarily.
- Viral infections: particularly seronegative hepatitis, where marrow failure follows an episode of hepatitis not caused by the usual hepatitis viruses.
- Pregnancy and autoimmune conditions: occasionally associated.
How the Marrow Fails
Healthy bone marrow relies on a small pool of stem cells that renew themselves while producing red cells, white cells, and platelets. To understand the background, see our overview of bone marrow composition and function.
In acquired aplastic anemia, activated cytotoxic T-lymphocytes release inflammatory signals such as interferon-gamma that drive stem cells to die. The fact that most patients improve with immunosuppressive therapy is strong evidence for this immune mechanism. In inherited forms, the stem cells themselves are fragile because of faulty DNA repair or shortened telomeres.
Symptoms and Diagnosis
Symptoms follow directly from which cell lines are low. Clinicians look for the classic pattern of bone marrow failure:
- Low red cells: fatigue, pallor, breathlessness, rapid heartbeat.
- Low platelets: easy bruising, nosebleeds, bleeding gums, and petechiae (pinpoint red spots on the skin).
- Low neutrophils: fevers, mouth ulcers, and recurrent or severe infections.
Because these signs can mimic many other hematological disorders, the workup is designed to exclude them. It typically includes a complete blood count with a reticulocyte count, which is low in aplastic anemia, a blood film to look for abnormal cells, and a bone marrow aspirate and trephine biopsy. The biopsy shows a hypocellular marrow without fibrosis or infiltration by cancer cells.
Further tests help rule out a hidden malignancy or overlap syndrome: flow cytometry for PNH clones, cytogenetics and molecular testing for MDS-associated changes, viral studies, vitamin B12 and folate levels, and, in younger patients, screening for inherited syndromes.
Severity is graded using blood counts and marrow cellularity. Disease is classed as severe when the marrow is markedly hypocellular and at least two of the following are present: neutrophils below 0.5 x 10⁹/L, platelets below 20 x 10⁹/L, or a very low reticulocyte count. Very severe disease means neutrophils below 0.2 x 10⁹/L.
Treatment Options
Treatment depends on severity, age, overall fitness, and whether a matched donor is available.
Stem Cell Transplantation
Hematopoietic stem cell transplantation (HSCT) replaces the failed marrow with healthy donor stem cells. It is the only treatment that can truly cure the disease and is generally the first choice for younger patients with severe disease and a matched sibling donor.
Immunosuppressive Therapy
For patients who are older or lack a suitable donor, immunosuppressive therapy with antithymocyte globulin (ATG) and cyclosporine is the mainstay. It works by switching off the immune attack so surviving stem cells can recover. The oral thrombopoietin receptor agonist eltrombopag is now commonly added, as it stimulates remaining stem cells and can improve recovery of all three cell lines.
Supportive Care
While waiting for a response, patients may need red cell and platelet transfusions, prompt antibiotics for fever, antifungal prophylaxis in selected cases, and iron chelation if repeated transfusions cause iron overload.
Research continues into better immunosuppressive combinations, alternative donor transplants, and gene-based approaches for inherited forms, building on the broader progress described in our guide to hematology and blood health.
When to See a Doctor
Seek medical assessment promptly if you notice unexplained bruising, frequent nosebleeds, pinpoint red spots, persistent fatigue, or infections that keep returning. A fever above 38°C (100.4°F) in someone known to have low neutrophils is a medical emergency.
If you already have aplastic anemia, keep regular follow-up even after counts recover. In my practice, periodic blood counts and occasional marrow checks are how we catch relapse or early clonal change. Caregivers may find our guide to hematological disorders for patients and caregivers useful.
Frequently Asked Questions
Is aplastic anemia considered a cancer?
No. It is a non-malignant bone marrow failure disorder in which the marrow is empty rather than overrun by cancer cells. It is managed by hematologist-oncologists because the tests, treatments, and risks overlap with blood cancers.
Can aplastic anemia turn into leukemia?
It can in a minority of patients. Over years, some develop an abnormal clone that progresses to myelodysplastic syndrome or acute myeloid leukemia, which is why long-term monitoring matters.
Is chemotherapy used to treat aplastic anemia?
Not in the usual anticancer sense. ATG and cyclosporine suppress the immune system rather than kill tumor cells. Conditioning chemotherapy is used only when preparing for a stem cell transplant.
Is aplastic anemia curable?
A successful stem cell transplant can cure it. Immunosuppressive therapy often restores good blood counts for long periods, although relapse can occur and ongoing follow-up is needed.
